LONG COVID MEDICATION AND METHOD OF TREATMENT

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250082677A1
SERIAL NO

18244569

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods of use for treatment of Long Covid, or other post-viral or other post-infection conditions that result in a toxin induced thickened blood pulp condition (e.g., including but not limited to influenza, zika, herpes, or epstein-barr viruses). The treatment composition includes C29H40N2O4; C9H2N2; and/or C28H38N2O4; and optionally a source of iron. A filler (e.g., CaCO3) or pharmaceutically acceptable carrier may be provided. In the treatment method, treatment composition is administered to a patient, specifically because of the patient's exhibition of symptoms of Long Covid (or other contemplated post-viral or other post-infection condition). The treatment composition can be administered as a single dose. The components thereof have a molecular and/or particle size sufficiently small so as to not induce vomiting, and the single dose administration to the patient is sufficient so that the patient's Long Covid symptoms are relieved within a period of about 10 days.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KIRSCHNER ELLENOBERTSHÄUSER STR 52 HEUSENSTAMM 63150

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kirschner, Ellen Huesenstamm, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation